Specifications
Species Reactivity
Mouse; Human
Immunogen
A region within synthetic peptide: DVAEYKEEEL LKDLEESVQD KNTNTLFSVK LEEELSVEGN TDINTDLKD, corresponding to C terminal amino acids 715-763 of Human SATB1
Applications
Application Notes
IP: 5 μg/ml; WB: 1.25 μg/ml; ICC/IF: 1/100.
Target
Alternative Names
SATB1; SATB homeobox 1; special AT rich sequence binding protein 1 (binds to nuclear matrix/scaffold associating DNA); DNA-binding protein SATB1; special AT-rich sequence-binding protein 1; special AT-rich sequence binding protein 1 (binds to nuclear matr
Product Background
Antigen Description
Crucial silencing factor contributing to the initiation of X inactivation mediated by Xist RNA that occurs during embryogenesis and in lymphoma (By similarity). Binds to DNA at special AT-rich sequences, the consensus SATB1-binding sequence (CSBS), at nuclear matrix- or scaffold-associated regions. Thought to recognize the sugar-phosphate structure of double-stranded DNA. Transcriptional repressor controlling nuclear and viral gene expression in a phosphorylated and acetylated status-dependent manner, by binding to matrix attachment regions (MARs) of DNA and inducing a local chromatin-loop remodeling. Acts as a docking site for several chromatin remodeling enzymes (e.g. PML at the MHC-I locus) and also by recruiting corepressors (HDACs) or coactivators (HATs) directly to promoters and enhancers. Modulates genes that are essential in the maturation of the immune T-cell CD8SP from thymocytes. Required for the switching of fetal globin species, and beta- and gamma-globin genes regulation during erythroid differentiation. Plays a role in chromatin organization and nuclear architecture during apoptosis. Interacts with the unique region (UR) of cytomegalovirus (CMV). Alu-like motifs and SATB1-binding sites provide a unique chromatin context which seems preferentially targeted by the HIV-1 integration machinery. Moreover, HIV-1 Tat may overcome SATB1-mediated repression of IL2 and IL2RA (interleukin) in T-cells by binding to the same domain than HDAC1. Delineates specific epigenetic modifications at target gene loci, directly upregulating metastasis-associated genes while downregulating tumor-suppressor genes. Reprograms chromatin organization and the transcription profiles of breast tumors to promote growth and metastasis.
Pathway
Apoptosis; Apoptotic cleavage of cellular proteins; Apoptotic executionphase; Caspase cascade in apoptosis;
Citations
Publication ()
Have you cited DPABH-16176 in a publication?
Let us know and earn a reward for your research.